These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24784775)

  • 1. The effects of neoadjuvant chemoradiotherapy on physical fitness and morbidity in rectal cancer surgery patients.
    West MA; Loughney L; Barben CP; Sripadam R; Kemp GJ; Grocott MP; Jack S
    Eur J Surg Oncol; 2014 Nov; 40(11):1421-8. PubMed ID: 24784775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prehabilitation on objectively measured physical fitness after neoadjuvant treatment in preoperative rectal cancer patients: a blinded interventional pilot study.
    West MA; Loughney L; Lythgoe D; Barben CP; Sripadam R; Kemp GJ; Grocott MP; Jack S
    Br J Anaesth; 2015 Feb; 114(2):244-51. PubMed ID: 25274049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of neoadjuvant chemoradiotherapy on whole-body physical fitness and skeletal muscle mitochondrial oxidative phosphorylation in vivo in locally advanced rectal cancer patients--an observational pilot study.
    West MA; Loughney L; Lythgoe D; Barben CP; Adams VL; Bimson WE; Grocott MP; Jack S; Kemp GJ
    PLoS One; 2014; 9(12):e111526. PubMed ID: 25478898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of neoadjuvant intensity-modulated radiotherapy with concurrent capecitabine for locally advanced rectal cancer.
    Wang L; Li ZY; Li ZW; Li YH; Sun YS; Ji JF; Gu J; Cai Y
    Dis Colon Rectum; 2015 Feb; 58(2):186-92. PubMed ID: 25585076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients (The EMPOWER Trial): study protocol for a randomised controlled trial.
    Loughney L; West MA; Kemp GJ; Rossiter HB; Burke SM; Cox T; Barben CP; Mythen MG; Calverley P; Palmer DH; Grocott MP; Jack S
    Trials; 2016 Jan; 17():24. PubMed ID: 26762365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise prehabilitation may lead to augmented tumor regression following neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    West MA; Astin R; Moyses HE; Cave J; White D; Levett DZH; Bates A; Brown G; Grocott MPW; Jack S
    Acta Oncol; 2019 May; 58(5):588-595. PubMed ID: 30724668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer - A comparison of magnetic resonance imaging at two time points and histopathological responses.
    West MA; Dimitrov BD; Moyses HE; Kemp GJ; Loughney L; White D; Grocott MP; Jack S; Brown G
    Eur J Surg Oncol; 2016 Sep; 42(9):1350-8. PubMed ID: 27160356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiopulmonary exercise testing for the prediction of morbidity risk after rectal cancer surgery.
    West MA; Parry MG; Lythgoe D; Barben CP; Kemp GJ; Grocott MP; Jack S
    Br J Surg; 2014 Aug; 101(9):1166-72. PubMed ID: 24916313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial.
    Morielli AR; Usmani N; Boulé NG; Severin D; Tankel K; Nijjar T; Joseph K; Fairchild A; Courneya KS
    Trials; 2018 Jan; 19(1):35. PubMed ID: 29329555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and preliminary effectiveness of a physical exercise training program during neoadjuvant chemoradiotherapy in individual patients with rectal cancer prior to major elective surgery.
    Heldens AF; Bongers BC; de Vos-Geelen J; van Meeteren NL; Lenssen AF
    Eur J Surg Oncol; 2016 Sep; 42(9):1322-30. PubMed ID: 27156145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for postoperative morbidity and tumour response after neoadjuvant chemoradiation followed by resection for rectal cancer.
    Berkel AE; Woutersen DP; van der Palen J; Klaase JM
    J Gastrointest Surg; 2014 Sep; 18(9):1648-57. PubMed ID: 24939597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of neoadjuvant chemotherapy and chemoradiotherapy on exercise capacity and outcome following upper gastrointestinal cancer surgery: an observational cohort study.
    West MA; Loughney L; Ambler G; Dimitrov BD; Kelly JJ; Mythen MG; Sturgess R; Calverley PM; Kendrick A; Grocott MP; Jack S
    BMC Cancer; 2016 Sep; 16(1):710. PubMed ID: 27589870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.
    Hofheinz RD; Wenz F; Post S; Matzdorff A; Laechelt S; Hartmann JT; Müller L; Link H; Moehler M; Kettner E; Fritz E; Hieber U; Lindemann HW; Grunewald M; Kremers S; Constantin C; Hipp M; Hartung G; Gencer D; Kienle P; Burkholder I; Hochhaus A
    Lancet Oncol; 2012 Jun; 13(6):579-88. PubMed ID: 22503032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
    Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
    Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour regression grading after chemoradiotherapy for locally advanced rectal cancer: a near pathologic complete response does not translate into good clinical outcome.
    Swellengrebel HA; Bosch SL; Cats A; Vincent AD; Dewit LG; Verwaal VJ; Nagtegaal ID; Marijnen CA
    Radiother Oncol; 2014 Jul; 112(1):44-51. PubMed ID: 25018000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of neoadjuvant chemotherapy on physical fitness and survival in patients undergoing oesophagogastric cancer surgery.
    Jack S; West MA; Raw D; Marwood S; Ambler G; Cope TM; Shrotri M; Sturgess RP; Calverley PM; Ottensmeier CH; Grocott MP
    Eur J Surg Oncol; 2014 Oct; 40(10):1313-20. PubMed ID: 24731268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic impact of neoadjuvant chemoradiotherapy on lymph node sampling in patients with locally advanced rectal cancer.
    Li Destri G; Maugeri A; Ramistella A; La Greca G; Conti P; Trombatore G; Vecchio GM; Magro GG; Barchitta M; Agodi A
    Updates Surg; 2020 Sep; 72(3):793-800. PubMed ID: 32632764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiopulmonary exercise testing for preoperative risk assessment before pancreaticoduodenectomy for cancer.
    Junejo MA; Mason JM; Sheen AJ; Bryan A; Moore J; Foster P; Atkinson D; Parker MJ; Siriwardena AK
    Ann Surg Oncol; 2014 Jun; 21(6):1929-36. PubMed ID: 24477709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between cardiopulmonary exercise testing and postoperative outcomes in patients with lung cancer undergoing lung resection surgery: A systematic review and meta-analysis.
    Arbee-Kalidas N; Moutlana HJ; Moodley Y; Kebalepile MM; Motshabi Chakane P
    PLoS One; 2023; 18(12):e0295430. PubMed ID: 38060569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?
    Bampo C; Alessi A; Fantini S; Bertarelli G; de Braud F; Bombardieri E; Valvo F; Crippa F; Di Bartolomeo M; Mariani L; Milione M; Biondani P; Avuzzi B; Chiruzzi C; Pietrantonio F
    Oncology; 2013; 84(4):191-9. PubMed ID: 23328390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.